Ultrasonic imaging probe for nanoscale disease diagnostics


Tuesday, 11 May, 2021



Ultrasonic imaging probe for nanoscale disease diagnostics

Scientists at the University of Nottingham have developed an ultrasonic imaging system that can be deployed on the tip of a hair-thin optical fibre, which will be insertable into the human body to visualise cell abnormalities in 3D.

Funded by the UK’s Engineering and Physical Sciences Research Council (EPSRC), the new technology produces microscopic- and nanoscopic-resolution images that will one day help clinicians to examine cells inhabiting hard-to-reach parts of the body, such as the gastrointestinal tract, and offer more effective diagnoses for diseases ranging from gastric cancer to bacterial meningitis. It has been described in the journal Light: Science & Applications.

How it works

Currently at prototype stage, the non-invasive imaging tool — described by the researchers as a ‘phonon probe’ — can be inserted into a standard optical endoscope, which is a thin tube with a powerful light and camera at the end that is navigated into the body to find, analyse and operate on cancerous lesions, among many other diseases. Combining optical and phonon technologies could be advantageous, speeding up the clinical workflow process and reducing the number of invasive test procedures for patients.

The ultrasonic imaging system uses two lasers that emit short pulses of energy to stimulate and detect vibrations in a specimen. One of the laser pulses is absorbed by a layer of metal known as a nano-transducer (which works by converting energy from one form to another), fabricated on the tip of the fibre; a process which results in high-frequency phonons (sound particles) getting pumped into the specimen. Then a second laser pulse collides with the soundwaves, a process known as Brillouin scattering.

By detecting these ‘collided’ laser pulses, the shape of the travelling soundwave can be recreated and displayed visually. The detected soundwave encodes information about the stiffness of a material, and even its geometry. The Nottingham team was the first to demonstrate this dual capability using pulsed lasers and optical fibres.

The power of an imaging device is typically measured by the smallest object that can be seen by the system, ie, the resolution. In two dimensions the phonon probe can ‘resolve’ objects on the order of 1 µm, similar to a microscope; but in the third dimension (height) it provides measurements on the scale of nanometres, which is unprecedented for a fibre-optic imaging system.

3D mapping capabilities

Just as a physician might conduct a physical examination to feel for abnormal ‘stiffness’ in tissue under the skin that could indicate tumours, the phonon probe will take this ‘3D mapping’ concept to a cellular level. By scanning the ultrasonic probe in space, it can reproduce a three-dimensional map of stiffness and spatial features of microscopic structures at, and below, the surface of a specimen (eg, tissue). It does this with the power to image small objects like a large-scale microscope, and the contrast to differentiate objects like an ultrasonic probe.

The high level of performance the technology delivers is currently only possible in state-of-the-art research labs with large, scientific instruments — whereas this compact system has the potential to bring it into clinical settings to improve patient care. The innovation also reduces the need for conventional fluorescent labels — chemicals used to examine cell biology under a microscope — which can be harmful to human cells in large doses.

“Techniques capable of measuring if a tumour cell is stiff have been realised with laboratory microscopes, but these powerful tools are cumbersome, immobile and unadaptable to patient-facing clinical settings,” said lead author Dr Salvatore La Cavera III, who holds an EPSRC Doctoral Prize Fellowship at the University of Nottingham. “Nanoscale ultrasonic technology in an endoscopic capacity is poised to make that leap.”

Future applications

In the paper, the researchers demonstrate that the technology is compatible with both a single optical fibre and the 10–20,000 fibres of an imaging bundle (1 mm in diameter), as used in conventional endoscopes. Consequently, superior spatial resolution and wide fields of view could routinely be achieved by collecting stiffness and spatial information from multiple different points on a sample, without needing to move the device — bringing a new class of phonon endoscopes within reach.

“We believe the system’s ability to measure the stiffness of a specimen, its biocompatibility and its endoscopic potential, all while accessing the nanoscale, are what set it apart,” Dr La Cavera said. “These features set the technology up for future measurements inside the body, towards the ultimate goal of minimally invasive point-of-care diagnostics.”

Beyond clinical health care, fields such as precision manufacturing and metrology could use the high-resolution tool for surface inspections and material characterisation, as a complementary or replacement measurement for existing scientific instruments. Burgeoning technologies such as 3D bioprinting and tissue engineering could also use the phonon probe as an inline inspection tool by integrating it directly to the outer diameter of the print-needle.

Next, the team will be developing a series of biological cell and tissue imaging applications, with the aim to create a viable clinical tool in the coming years.

Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.

Related Articles

Mini spectrometer could be integrated into smartphones

Researchers are developing a chip spectrometer, weighing just one gram, that could be used for...

'Digital Dog Nose' can identify explosives, drugs and more

The sensor can detect threats at the molecular level — whether it's explosive...

Understanding measurement uncertainty

For any important measurement, it is essential to identify every source of uncertainty and to...


  • All content Copyright © 2021 Westwick-Farrow Pty Ltd